Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis | PLOS ONE
Serum free light chain immunoassays and their clinical application - ScienceDirect
Serum Free Light Chain | | Content Tag
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent | Semantic Scholar
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Immunoglobulin‐free light chain monomer‐dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: A pilot study - Kaplan - 2014 - American Journal of Hematology - Wiley Online Library
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
PDF) Immunoglobulin Free Light Chain Dimers in Human Diseases
TECHNICALREVIEW
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis | Neurology Neuroimmunology & Neuroinflammation
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
![Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/13385/1/fig-1-full.png "Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]")
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
PDF) Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?
JaypeeDigital | eBook Reader
Measurement of kappa () and lambda () light chains in free and total... | Download High-Quality Scientific Diagram
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
